Organization

VA Office of Research and Development

116 clinical trials

Clinical trial
Beta Adrenergic Antagonist For The Healing of Chronic Diabetic Foot Ulcers
Status: Completed, Estimated PCD: 2023-12-01
Clinical trial
Repetitive Acute Intermittent Hypoxia for Spinal Cord Repair
Status: Recruiting, Estimated PCD: 2025-02-10
Clinical trial
Fecal Microbiota Transplant in Veterans With Cirrhosis
Status: Completed, Estimated PCD: 2023-12-19
Clinical trial
Optimal Treatment of Veterans With PTSD and Comorbid Opiate Use Disorder (OUD)
Status: Terminated, Estimated PCD: 2023-04-14
Clinical trial
Hydroxychloroquine for the Management of CVD in CKD
Status: Completed, Estimated PCD: 2024-01-31
Clinical trial
Phase II Trial of Targeted Radiation With no Castration for Mcrpc
Status: Recruiting, Estimated PCD: 2027-11-29
Clinical trial
Microbiome Targeted Oral Butyrate Therapy in Gulf War Multisymptom Illness
Status: Recruiting, Estimated PCD: 2025-01-10
Clinical trial
Noradrenergic Biomarkers in PTSD: Precision Medicine & Mechanisms
Status: Recruiting, Estimated PCD: 2024-06-28
Clinical trial
Novel Regenerative Therapeutic in Chronic Complex TBI
Status: Not yet recruiting, Estimated PCD: 2024-09-30
Clinical trial
Impact of Icosapent Ethyl on Alzheimers Disease Biomarkers in Preclinical Adults
Status: Completed, Estimated PCD: 2023-09-29
Clinical trial
CSP #594 - Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat
Status: Completed, Estimated PCD: 2021-02-01
Clinical trial
Stroke and Coated-Platelets - A Translational Research Initiative
Status: Recruiting, Estimated PCD: 2025-04-30
Clinical trial
Prazosin and CSF Biomarkers in mTBI
Status: Terminated, Estimated PCD: 2023-01-03
Clinical trial
Million Veteran Program Return of Actionable Results
Status: , Estimated PCD: 2024-09-30
Clinical trial
MitoQ for Fatigue in Multiple Sclerosis: A Placebo Controlled Trial
Status: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
Ketamine for The Rapid Treatment of Major Depression and Alcohol Use Disorder
Status: Completed, Estimated PCD: 2023-10-30
Clinical trial
Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis
Status: Recruiting, Estimated PCD: 2026-12-31
Clinical trial
Treating Early Stage Diabetic Retinopathy
Status: , Estimated PCD: 2027-12-31
Clinical trial
Repositioning Immunotherapy in Veterans With Lung Cancer
Status: Recruiting, Estimated PCD: 2027-02-28
Clinical trial
Cannabidiol as an Adjunctive to Prolonged Exposure for the Treatment of PTSD
Status: Recruiting, Estimated PCD: 2024-09-30
Clinical trial
Leucoselect Phytosome for Neoadjuvant Treatment of Early Stage Lung Cancer
Status: Recruiting, Estimated PCD: 2027-01-04
Clinical trial
Proof of Concept Trial of Cannabis Derivatives in Neuropathic Pain.
Status: Active (not recruiting), Estimated PCD: 2027-06-30
Clinical trial
Higher-Than-Replacement Testosterone Plus Finasteride Treatment After SCI
Status: Terminated, Estimated PCD: 2021-08-13
Clinical trial
Varenicline for Comorbid Tobacco and Cannabis Use in Veterans
Status: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Using SMART Design to Develop Dynamic Treatment Regimens for Glucocorticoid Tapering
Status: Recruiting, Estimated PCD: 2029-03-01
Clinical trial
CSP #590 - Lithium for Suicidal Behavior in Mood Disorders
Status: Terminated, Estimated PCD: 2019-08-13
Clinical trial
Clinical and Imaging Biomarker Trial of Uridine for Veterans With Suicidal Ideation
Status: Active (not recruiting), Estimated PCD: 2024-06-30
Clinical trial
VA Aripiprazole vs. Esketamine for Treatment of Depression VAST-D II
Status: Withdrawn, Estimated PCD: 2023-10-27
Clinical trial
Lifestyle Intervention Plus Metformin to Treat Frailty in Older Veterans With Obesity
Status: Recruiting, Estimated PCD: 2025-09-30
Clinical trial
Neurosteroid Intervention for PTSD in Iraq/Afghanistan-era Veterans
Status: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Chronic Postconcussive Headache: A Placebo-Controlled Treatment Trial of Prazosin
Status: Completed, Estimated PCD: 2023-05-31
Clinical trial
Metabolic Effects of Natriuretic Peptide Hormones
Status: Terminated, Estimated PCD: 2019-05-01
Clinical trial
Harnessing Allo-immunity to Enhance Immune Checkpoint Inhibitor Responses in Advanced NSCLC
Status: Not yet recruiting, Estimated PCD: 2026-06-22
Clinical trial
A New Intervention to Improve Function in Veterans With Anxiety and Depression
Status: Not yet recruiting, Estimated PCD: 2028-06-30
Clinical trial
Pimavanserin for Insomnia in Veterans With Post-traumatic Stress Disorder
Status: Recruiting, Estimated PCD: 2027-07-12
Clinical trial
Novel Combination Therapy for Osteoporosis in Men
Status: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
Effects of Electrical Stimulation and Vitamin D Supplementation on Bone Health Following Spinal Cord Injury.
Status: Active (not recruiting), Estimated PCD: 2024-06-30
Clinical trial
Vitamin D3 Supplementation for Low-Risk Prostate Cancer: A Randomized Trial
Status: Completed, Estimated PCD: 2018-10-18
Clinical trial
Preventing Diabetic Foot Ulcers Through Manipulating the Skin Microbiota
Status: Completed, Estimated PCD: 2022-12-30
Clinical trial
A Phase I Trial of Cancer-targeting Micelles for Non-myoinvasive Bladder Cancer
Status: Recruiting, Estimated PCD: 2026-08-31
Clinical trial
Metformin BenefIts Lower Extremities With Intermittent Claudication (MOBILE_IC)
Status: Recruiting, Estimated PCD: 2026-02-28
Clinical trial
Effect of Simvastatin on Hepatic Decompensation and Death in Subjects With High-risk Compensated Cirrhosis
Status: Active (not recruiting), Estimated PCD: 2025-12-31
Clinical trial
Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson Disease
Status: Completed, Estimated PCD: 2023-09-08
Clinical trial
Pathophysiology-Guided Therapy for Sleep Apnea in the Elderly
Status: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism
Status: Recruiting, Estimated PCD: 2024-09-30
Clinical trial
The Effect of an Oral Beta-2 Agonist on Respiratory Muscle Strength in SCI
Status: Terminated, Estimated PCD: 2022-03-02
Clinical trial
Enhancing Prolonged Exposure Therapy for PTSD With Oxytocin
Status: Recruiting, Estimated PCD: 2025-02-28
Clinical trial
Preventing Levodopa Induced Dyskinesia in Parkinson?s Disease With Statins
Status: Recruiting, Estimated PCD: 2026-07-01
Clinical trial
Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia
Status: Active (not recruiting), Estimated PCD: 2024-06-30
Clinical trial
Care Management for the Effective Use of Opioids (CAMEO)
Status: Completed, Estimated PCD: 2015-12-11
Clinical trial
Tobacco Cessation Treatment Preferences Among Veteran Smokers (CDA 17-005)
Status: Completed, Estimated PCD: 2023-09-27
Clinical trial
An Electrophysiological Predictor of SSRI Response in Veterans With PTSD
Status: Recruiting, Estimated PCD: 2025-03-30
Clinical trial
Precision Neoadjuvant Therapy for High Risk Localized Prostate Cancer With PTEN Loss
Status: Recruiting, Estimated PCD: 2027-05-01
Clinical trial
Combining Topiramate and Prolonged Exposure for PTSD and Alcohol Use Disorder
Status: Completed, Estimated PCD: 2022-10-31
Clinical trial
Comparative Effectiveness of Split-Dose Colonoscopy Bowel Preparation Regimens
Status: Active (not recruiting), Estimated PCD: 2023-12-30
Clinical trial
Effect of PDE5 Inhibitor on Respiratory Symptoms in COPD Complicated by Pulmonary Hypertension
Status: Not yet recruiting, Estimated PCD: 2027-06-01
Clinical trial
Repeated Ketamine Treatment to Accelerate Efficacy of Prolonged Exposure in PTSD
Status: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Does Variation in Mean Red Cell Age Impact HbA1C Interpretation?
Status: Terminated, Estimated PCD: 2016-07-01
Clinical trial
Lipoic Acid for the Treatment of Progressive Multiple Sclerosis
Status: Active (not recruiting), Estimated PCD: 2023-12-31
Clinical trial
CPT-SMART for Treatment of PTSD and Cigarette Smoking
Status: Recruiting, Estimated PCD: 2024-09-30
Clinical trial
Intravenous Sub-anesthetic Ketamine Treatment in Treatment-Resistant Depression
Status: Completed, Estimated PCD: 2018-10-22
Clinical trial
Discontinuing NSAIDs in Veterans With Knee Osteoarthritis
Status: Completed, Estimated PCD: 2018-10-05
Clinical trial
Topiramate Treatment of Alcohol Use Disorder in African Americans
Status: Terminated, Estimated PCD: 2021-12-31
Clinical trial
Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer
Status: Completed, Estimated PCD: 2024-03-31
Clinical trial
Allopurinol Improves Diastolic Function in African Americans With Resistant Hypertension
Status: Recruiting, Estimated PCD: 2025-03-26
Clinical trial
Passive Limb Movement: A Tool to Assess Vascular Health and Guide Rehabilitation
Status: Recruiting, Estimated PCD: 2025-10-31
Clinical trial
Induction of Sensecence Using Dexamethasone to Re-sensitize NSCLC to Anti-PD1 Therapy
Status: Completed, Estimated PCD: 2022-12-09
Clinical trial
Nitrous Oxide for Posttraumatic Stress Disorder (PTSD): A Phase IIa Trial
Status: Terminated, Estimated PCD: 2022-08-31
Clinical trial
Anti-inflammatory Therapy During Percutaneous Coronary Intervention
Status: Completed, Estimated PCD: 2019-08-30
Clinical trial
Central Sleep Apnea: Physiologic Mechanisms to Inform Treatment
Status: Recruiting, Estimated PCD: 2025-06-30
Clinical trial
Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI
Status: Active (not recruiting), Estimated PCD: 2026-02-05
Clinical trial
Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans
Status: Active (not recruiting), Estimated PCD: 2022-06-30
Clinical trial
Mechanisms of Erythropoietin Induced Hypertension
Status: Active (not recruiting), Estimated PCD: 2024-12-31
Clinical trial
Neurosteroids in PTSD - Biomarkers to Therapeutics
Status: Terminated, Estimated PCD: 2020-11-16
Clinical trial
Treatment of Veterans With Heart Failure With Reduced Ejection Fraction With Probenecid
Status: Recruiting, Estimated PCD: 2025-05-30